Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Welti

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Demography|November 1, 1981
Community availability of contraceptives and family limitationA O Tsui, D P Hogan, J D Teachman, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 13, 2009
Whole-mount assays for gene induction and barrier formation in the developing epidermisCarolyn Byrne, Ariel A Avilion, Ryan F O'Shaughnessy, et al.
Boletin Medico Del Hospital Infantil De Mexico|June 1, 1993
[The management of diarrheal disease at home in some regions of Mexico]F Mota-Hernández, R Tapia-Conyer, C Welti, et al.
Oncogene|November 9, 2010
Fibroblast growth factor 2 regulates endothelial cell sensitivity to sunitinibJ C Welti, M Gourlaouen, T Powles, et al.
The Journal of Biological Chemistry|April 19, 2007
AKT-dependent HspB1 (Hsp27) activity in epidermal differentiationRyan F L O'Shaughnessy, Jonathan C Welti, James C Cooke, et al.
Nature Reviews. Clinical Oncology|August 24, 2018
Alternative splicing in prostate cancerAlec Paschalis, Adam Sharp, Jonathan C Welti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2019
Dissecting Prognostic From Predictive Utility: Circulating AR-V7 Biomarker Testing for Advanced Prostate CancerAdam Sharp, Nuria Porta, Maryou B K Lambros, et al.
Cancer Research|November 29, 2012
Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesisAnn-Marie Baker, Demelza Bird, Jonathan C Welti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2011
FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivoRachel Sharpe, Alex Pearson, Maria T Herrera-Abreu, et al.
Molecular Cancer Therapeutics|October 22, 2015
Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell CarcinomaVictoria L Bridgeman, Elaine Wan, Shane Foo, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Demography|November 1, 1981
Community availability of contraceptives and family limitationA O Tsui, D P Hogan, J D Teachman, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 13, 2009
Whole-mount assays for gene induction and barrier formation in the developing epidermisCarolyn Byrne, Ariel A Avilion, Ryan F O'Shaughnessy, et al.
Boletin Medico Del Hospital Infantil De Mexico|June 1, 1993
[The management of diarrheal disease at home in some regions of Mexico]F Mota-Hernández, R Tapia-Conyer, C Welti, et al.
Oncogene|November 9, 2010
Fibroblast growth factor 2 regulates endothelial cell sensitivity to sunitinibJ C Welti, M Gourlaouen, T Powles, et al.
The Journal of Biological Chemistry|April 19, 2007
AKT-dependent HspB1 (Hsp27) activity in epidermal differentiationRyan F L O'Shaughnessy, Jonathan C Welti, James C Cooke, et al.
Nature Reviews. Clinical Oncology|August 24, 2018
Alternative splicing in prostate cancerAlec Paschalis, Adam Sharp, Jonathan C Welti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2019
Dissecting Prognostic From Predictive Utility: Circulating AR-V7 Biomarker Testing for Advanced Prostate CancerAdam Sharp, Nuria Porta, Maryou B K Lambros, et al.
Cancer Research|November 29, 2012
Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesisAnn-Marie Baker, Demelza Bird, Jonathan C Welti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2011
FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivoRachel Sharpe, Alex Pearson, Maria T Herrera-Abreu, et al.
Molecular Cancer Therapeutics|October 22, 2015
Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell CarcinomaVictoria L Bridgeman, Elaine Wan, Shane Foo, et al.
Pageof 3